Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
20-HETE inhibitor-2
Cat. No.:
OB0425LY-207
Appearance:
Solid
Purity:
98.12%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
20-HETE inhibitor-2 is a potent inhibitor of 20-HETE. 20-HETE is a biologically active fatty acid that has been implicated in several cardiovascular diseases. This inhibitor interferes with the biosynthesis of 20-HETE.
Synonyms:
20-HETE inhibitor 2;2992666-48-3
CAS No.:
2992666-48-3
Compound CID:
169094784
Formula:
C19H23FN4O
Formula Weight:
342.41
Specification
Target:
Cytochrome P450
Pathway:
Metabolic enzyme/Protease
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
20-HETE inhibitor-2 can be used in studies of cardiovascular disease, kidney disease, and hypertension.
